In the SURPASS-2 study, tirzepatide 15 mg resulted in a faster and greater decline in body weight ( 5.5 kg) compared to semaglutide 1.0 mg, more than doubling the proportion of patients achieving at least 10% weight loss (57% vs 24%) [3]
Current evidence does not support the simplistic claim that GLP-1 medications uniquely melt muscle. Weight loss produced by medication, calorie restriction, bariatric surgery, or intensive lifestyle intervention commonly includes some reduction in lean tissue
Despite these promising developments, GLP-1 therapies remain relatively new
That doesnt necessarily make them dangerous but it does mean Im trusting my health to a supply chain that barely exists
Lower consumption growth could make this trend worse and put heavy pressure on the local milling sector
The Rise of DIY & Gray Market GLP-1 Sales Gray market GLP-1 drugs are often purchased from online vendors, overseas pharmacies, compounding labs, or social media sellers without FDA oversight